About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETED

Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir

NCT02532673•Bristol-Myers Squibb

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

HIV/AIDS

Key Dates

Start Date

August 1, 2014

Primary Completion Date

May 1, 2015

Completion Date

May 1, 2015

Last Updated

August 26, 2015

Related Studies

MyPEEPS LITE Trial

NCT06741631

MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM

NCT06741618

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing

NCT07072481

HIV/AIDSSexually Transmitted Diseases

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

NCT03135886

HIV/AIDSHepatitis C+2 more

An Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in Malawi

NCT06367348

HIV/AIDSAlcohol Abuse

Prevent TB: Choice Architecture for TPT Delivery

NCT04466488

HIV/AIDSTuberculosis

View all related studies

Sponsors

Lead Sponsor

Bristol-Myers Squibb

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 26, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions